Other genes that were more frequently mutated in MET -altered LUAD BMs but did not reach statistical significance included CDKN2A (16% vs. 7%; P = 0.19), RET (16% vs. 9%; P = 0.29), ABL1 (13% vs. 2%; P = 0.09), IDH1 (10% vs. 0%; P = 0.07), and ALK (10% vs. 5%; P = 0.35).
← all excerpts
MET alterations are enriched in lung adenocarcinoma brain metastases, defining a distinct biologic subtype.
1
0.1900
0.1900